Yuxi Lin
Chungbuk, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 53 publications
Amyloid fibrils in Alzheimer's disease differently modulate sleep and cortical oscillations in mice depending on the type of amyloid.
Journal: Biophysical chemistry
Published: December 10, 2025
Concentration-dependent structural transition of huntingtin protein in Huntington's disease.
Journal: Biophysical chemistry
Published: May 20, 2025
Disease-disease interactions: molecular links of neurodegenerative diseases with cancer, viral infections, and type 2 diabetes.
Journal: Translational neurodegeneration
Published: February 04, 2025
Graphene Quantum Dots Attenuate TDP-43 Proteinopathy in Amyotrophic Lateral Sclerosis.
Journal: ACS nano
Published: February 04, 2025
Distinct Aggregation Behavior of N-Terminally Truncated Aβ4-42 Over Aβ1-42 in the Presence of Zn(II).
Journal: ACS chemical neuroscience
Published: January 30, 2025
Ca2+-driven PDIA6 biomolecular condensation ensures proinsulin folding.
Journal: Nature cell biology
Published: September 30, 2024
Crystal structure of pectocin M1 reveals diverse conformations and interactions during its initial step via the ferredoxin uptake system.
Journal: FEBS open bio
Published: June 01, 2024
Complement receptor 4 mediates the clearance of extracellular tau fibrils by microglia.
Journal: The FEBS journal
Published: November 09, 2023
APP-C31: An Intracellular Promoter of Both Metal-Free and Metal-Bound Amyloid-β40 Aggregation and Toxicity in Alzheimer's Disease.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: September 28, 2023
Interactions with tau's microtubule-binding repeats modulate amyloid-β aggregation and toxicity.
Journal: Nature chemical biology
Published: September 08, 2023
Diselenide-bond replacement of the external disulfide bond of insulin increases its oligomerization leading to sustained activity.
Journal: Communications chemistry
Published: July 21, 2023
The dopamine analogue CA140 alleviates AD pathology, neuroinflammation, and rescues synaptic/cognitive functions by modulating DRD1 signaling or directly binding to Abeta.
Journal: Journal of neuroinflammation
Published: July 10, 2023
Last Updated: 09/26/2026